The role of schedule dependency of 5-fluorouracil/leucovorin combinations in advanced colorectal cancer.
C. Schöber, H. Poliwoda, Michael Ståhl(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Carsten Bokemeyer(Universität Hamburg), Hans‐Joachim Wilke(Helmholtz-Institute Ulm), Hans‐Joachim Schmoll(Martin Luther University Halle-Wittenberg)
PubMed
April 1, 1992
Cited by 10
Related Papers
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
|Annals of Internal Medicine|2020|2.4k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
|The Lancet Oncology|2008|1.1k